HomeNWBO • OTCMKTS
add
Northwest Biotherapeutics Inc
Nakaraang pagsara
$0.29
Sakop ng araw
$0.26 - $0.37
Sakop ng taon
$0.17 - $0.54
Market cap
472.18M USD
Average na Volume
4.74M
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 231.00K | -48.09% |
Gastos sa pagpapatakbo | 8.21M | 0.91% |
Net na kita | -28.22M | -101.92% |
Net profit margin | -12.22K | -288.99% |
Kita sa bawat share | — | — |
EBITDA | -18.06M | -22.72% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.18M | 2.30% |
Kabuuang asset | 26.73M | -4.08% |
Kabuuang sagutin | 105.71M | 41.09% |
Kabuuang equity | -78.98M | — |
Natitirang share | 1.39B | — |
Presyo para makapag-book | -4.14 | — |
Return on assets | -165.03% | — |
Return on capital | 530.21% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -28.22M | -101.92% |
Cash mula sa mga operasyon | -20.18M | -19.01% |
Cash mula sa pag-invest | -78.00K | 81.34% |
Cash mula sa financing | 15.94M | 10.59% |
Net change in cash | -764.00K | 80.76% |
Malayang cash flow | -7.97M | 23.95% |
Tungkol
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
Itinatag
Ene 1, 1998
Website
Mga Empleyado
25
